Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 41

    1.

    Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.

    Shepp DH, Curtis S, Rooney JF.

    AIDS. 2007 Jul 11;21(11):1479-81.PMID: 17589195 [PubMed - indexed for MEDLINE]Related articles

    2.

    Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.

    Winston J, Shepp DH.

    HIV Med. 2006 Oct;7(7):484-5. No abstract available. PMID: 16925736 [PubMed - indexed for MEDLINE]Related articles

    3.

    The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.

    Winston JA, Shepp DH.

    Clin Infect Dis. 2006 Jun 1;42(11):1657-8; author reply 1658. No abstract available. PMID: 16652330 [PubMed - indexed for MEDLINE]Related articles

    4.

    Macrophage inflammatory protein 1alpha inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP.

    Amella CA, Sherry B, Shepp DH, Schmidtmayerova H.

    J Virol. 2005 May;79(9):5625-31.PMID: 15827177 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults.

    Ruane PJ, Parenti DM, Margolis DM, Shepp DH, Babinchak TJ, Van Kempen AS, Kauf TL, Danehower SA, Yau L, Hessenthaler SM, Goodwin D, Hernandez JE; COL30336 Study Team.

    HIV Clin Trials. 2003 Jul-Aug;4(4):231-43.PMID: 12916008 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration.

    Lipson SM, Shepp DH, Match ME, Axelrod FB, Whitbread JA.

    Am J Clin Pathol. 2001 Jul;116(1):52-5.PMID: 11447751 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Stavudine resistance: an update on susceptibility following prolonged therapy.

    Lin PF, González CJ, Griffith B, Friedland G, Calvez V, Ferchal F, Schinazi RF, Shepp DH, Ashraf AB, Wainberg MA, Soriano V, Mellors JW, Colonno RJ.

    Antivir Ther. 1999;4(1):21-8.PMID: 10682125 [PubMed - indexed for MEDLINE]Related articles

    8.

    Evaluation of the PrimeCapture CMV DNA detection plate system for detection of cytomegalovirus in clinical specimens.

    Davoli EH, Lipson SM, Match ME, Shepp DH, Morin JW, Curley DM.

    J Clin Microbiol. 1999 Aug;37(8):2587-91.PMID: 10405406 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Application of a standardized cytomegalovirus antigenemia assay in the management of patients with AIDS.

    Lipson SM, Match ME, Toro AI, Kaplan MH, Shepp DH.

    Diagn Microbiol Infect Dis. 1998 Oct;32(2):75-9.PMID: 9823528 [PubMed - indexed for MEDLINE]Related articles

    10.

    Identification of an exogenous retrovirus (foamy virus type 1) in rhesus monkey kidney cell culture: significance to viral diagnostics.

    Lipson SM, Match ME, Shepp DH, Lotlikar MS, Teichberg S, Pergolizzi R.

    J Clin Virol. 1998 Aug 20;11(2):149-53. No abstract available. PMID: 9785216 [PubMed - indexed for MEDLINE]Related articles

    11.

    A fifth human cytomegalovirus glycoprotein B genotype.

    Shepp DH, Match ME, Lipson SM, Pergolizzi RG.

    Res Virol. 1998 Mar-Apr;149(2):109-14.PMID: 9602505 [PubMed - indexed for MEDLINE]Related articles

    12.

    Significance of leukocyte concentration in the performance of the quantitative cytomegalovirus (CMV) antigenemia assay.

    Lipson SM, Toro A, Lotlikar M, Match ME, Kaplan MH, Shepp DH, Gong J.

    Clin Diagn Virol. 1997 Aug;8(2):151-8.PMID: 9316736 [PubMed - indexed for MEDLINE]Related articles

    13.

    A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.

    Shepp DH, Ramirez-Ronda C, Dall L, Pollard RB, Murphy RL, Kessler H, Sherer R, Mertz G, Perez G, Gocke DJ, Greenberg SB, Petersen E, Frank I, Moore MD, McKinnis R, Rooney JF.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):283-8.PMID: 9292587 [PubMed - indexed for MEDLINE]Related articles

    14.

    Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance.

    Lipson SM, Soni M, Biondo FX, Shepp DH, Kaplan MH, Sun T.

    Diagn Microbiol Infect Dis. 1997 Jul;28(3):123-9.PMID: 9294702 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antiretroviral agents. Current usage.

    Chaudry MN, Shepp DH.

    Dermatol Clin. 1997 Apr;15(2):319-29. Review.PMID: 9098641 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

    Balfour HH Jr, Fletcher CV, Erice A, Henry WK, Acosta EP, Smith SA, Holm MA, Boivin G, Shepp DH, Crumpacker CS, Eaton CA, Martin-Munley SS.

    Antimicrob Agents Chemother. 1996 Dec;40(12):2721-6.PMID: 9124829 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection.

    Wallace MR, Moss RB, Beecham HJ 3rd, Grace CJ, Hersh EM, Peterson E, Murphy R, Shepp DH, Siegal FP, Turner JL, Safrin S, Carlo DJ, Levine AM.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):358-62.PMID: 8673544 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS.

    Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R.

    J Infect Dis. 1996 Jul;174(1):184-7.PMID: 8655991 [PubMed - indexed for MEDLINE]Related articles

    20.

    Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival.

    Shepp DH, Moses JE, Kaplan MH.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15;11(5):460-8.PMID: 8605591 [PubMed - indexed for MEDLINE]Related articles

    21.

    Cell culture-PCR technique for detection of infectious cytomegalovirus in peripheral blood.

    Lipson SM, Ashraf AB, Lee SH, Kaplan MH, Shepp DH.

    J Clin Microbiol. 1995 May;33(5):1411-3.PMID: 7615769 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Serious Pseudomonas aeruginosa infection in AIDS.

    Shepp DH, Tang IT, Ramundo MB, Kaplan MK.

    J Acquir Immune Defic Syndr. 1994 Aug;7(8):823-31.PMID: 8021816 [PubMed - indexed for MEDLINE]Related articles

    24.

    Herpes simplex virus infection in cancer patients: prevention and treatment.

    Tang IT, Shepp DH.

    Oncology (Williston Park). 1992 Jul;6(7):101-6, 109; discussion 109-10. Review.PMID: 1322152 [PubMed - indexed for MEDLINE]Related articles

    25.

    Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.

    Ljungman P, Ellis MN, Hackman RC, Shepp DH, Meyers JD.

    J Infect Dis. 1990 Jul;162(1):244-8.PMID: 2162368 [PubMed - indexed for MEDLINE]Related articles

    26.

    Ineffectiveness of vidarabine in mucocutaneous herpes simplex virus infection.

    Shepp DH, Farber BF.

    Lancet. 1990 Jun 2;335(8701):1344. No abstract available. PMID: 1971402 [PubMed - indexed for MEDLINE]Related articles

    27.

    Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.

    Shepp DH, Dandliker PS, Meyers JD.

    Am J Med. 1988 Aug 29;85(2A):96-8.PMID: 3044102 [PubMed - indexed for MEDLINE]Related articles

    28.

    Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus.

    Shepp DH, Chakrabarti S, Moss B, Quinnan GV Jr.

    J Infect Dis. 1988 Jun;157(6):1260-4. No abstract available. PMID: 3163712 [PubMed - indexed for MEDLINE]Related articles

    29.

    Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.

    Vujcic LK, Shepp DH, Klutch M, Wells MA, Hendry RM, Wittek AE, Krilov L, Quinnan GV Jr.

    J Infect Dis. 1988 May;157(5):1047-50. No abstract available. PMID: 3162928 [PubMed - indexed for MEDLINE]Related articles

    30.

    Ganciclovir treatment of cytomegalovirus infection of the gastrointestinal tract after marrow transplantation.

    Reed EC, Shepp DH, Dandliker PS, Meyers JD.

    Bone Marrow Transplant. 1988 May;3(3):199-206.PMID: 2844343 [PubMed - indexed for MEDLINE]Related articles

    31.

    Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.

    Shepp DH, Daguillard F, Mann D, Quinnan GV.

    AIDS. 1988 Apr;2(2):113-7.PMID: 2454643 [PubMed - indexed for MEDLINE]Related articles

    32.

    Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.

    Meyers JD, Reed EC, Shepp DH, Thornquist M, Dandliker PS, Vicary CA, Flournoy N, Kirk LE, Kersey JH, Thomas ED, et al.

    N Engl J Med. 1988 Jan 14;318(2):70-5.PMID: 2827025 [PubMed - indexed for MEDLINE]Related articles

    33.

    Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.

    Shepp DH, Dandliker PS, Flournoy N, Meyers JD.

    Transplantation. 1987 May;43(5):654-8.PMID: 3554658 [PubMed - indexed for MEDLINE]Related articles

    34.

    Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.

    Shepp DH, Dandliker PS, Meyers JD.

    N Engl J Med. 1986 Jan 23;314(4):208-12.PMID: 3001523 [PubMed - indexed for MEDLINE]Related articles

    35.

    Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.

    Shepp DH, Klosterman A, Siegel MS, Meyers JD.

    J Infect Dis. 1985 Dec;152(6):1257-63.PMID: 3905986 [PubMed - indexed for MEDLINE]Related articles

    36.

    Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.

    Shepp DH, Dandliker PS, Flournoy N, Meyers JD.

    J Antimicrob Chemother. 1985 Sep;16(3):389-95.PMID: 2997101 [PubMed - indexed for MEDLINE]Related articles

    37.

    Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.

    Shepp DH, Dandliker PS, de Miranda P, Burnette TC, Cederberg DM, Kirk LE, Meyers JD.

    Ann Intern Med. 1985 Sep;103(3):368-73.PMID: 2992333 [PubMed - indexed for MEDLINE]Related articles

    38.

    Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture.

    Shepp DH, Hackman RC, Conley FK, Anderson JB, Meyers JD.

    Ann Intern Med. 1985 Aug;103(2):218-21.PMID: 3893254 [PubMed - indexed for MEDLINE]Related articles

    39.

    Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.

    Shepp DH, Newton BA, Dandliker PS, Flournoy N, Meyers JD.

    Ann Intern Med. 1985 Jun;102(6):783-5.PMID: 2986508 [PubMed - indexed for MEDLINE]Related articles

    40.

    Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegaloviral pneumonia.

    Shepp DH, Newton BA, Meyers JD.

    J Infect Dis. 1984 Nov;150(5):776-7. No abstract available. PMID: 6092489 [PubMed - indexed for MEDLINE]Related articles

    41.

    Acyclovir treatment of varicella-zoster virus infection in the compromised host.

    Meyers JD, Wade JC, Shepp DH, Newton B.

    Transplantation. 1984 Jun;37(6):571-4.PMID: 6328703 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...